Masimo Co. (MASI) Shares Sold by Allianz Asset Management GmbH
Allianz Asset Management GmbH trimmed its position in shares of Masimo Co. (NASDAQ:MASI) by 12.2% during the 4th quarter, HoldingsChannel reports. The firm owned 402,209 shares of the medical equipment provider’s stock after selling 55,923 shares during the quarter. Allianz Asset Management GmbH’s holdings in Masimo were worth $34,107,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of MASI. Bank of New York Mellon Corp boosted its stake in shares of Masimo by 6.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,074,648 shares of the medical equipment provider’s stock valued at $93,021,000 after buying an additional 64,882 shares during the period. Old Mutual Global Investors UK Ltd. boosted its stake in shares of Masimo by 9.0% during the 4th quarter. Old Mutual Global Investors UK Ltd. now owns 881,000 shares of the medical equipment provider’s stock valued at $74,708,000 after buying an additional 72,512 shares during the period. JPMorgan Chase & Co. boosted its stake in shares of Masimo by 6.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 851,234 shares of the medical equipment provider’s stock valued at $72,278,000 after buying an additional 48,536 shares during the period. Prudential Financial Inc. boosted its stake in shares of Masimo by 23.9% during the 3rd quarter. Prudential Financial Inc. now owns 685,268 shares of the medical equipment provider’s stock valued at $59,317,000 after buying an additional 132,053 shares during the period. Finally, American Century Companies Inc. boosted its stake in shares of Masimo by 23.1% during the 4th quarter. American Century Companies Inc. now owns 587,070 shares of the medical equipment provider’s stock valued at $49,784,000 after buying an additional 110,107 shares during the period. Hedge funds and other institutional investors own 82.18% of the company’s stock.
A number of brokerages have issued reports on MASI. Zacks Investment Research lowered shares of Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 7th. Piper Jaffray Companies reissued a “hold” rating and set a $91.00 target price on shares of Masimo in a research note on Thursday. Finally, BidaskClub raised shares of Masimo from a “sell” rating to a “hold” rating in a research note on Thursday. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $102.33.
Shares of Masimo Co. (NASDAQ MASI) opened at $84.47 on Friday. Masimo Co. has a 52 week low of $80.69 and a 52 week high of $104.71. The stock has a market cap of $4,490.00, a price-to-earnings ratio of 26.90, a P/E/G ratio of 2.16 and a beta of 0.91.
Masimo (NASDAQ:MASI) last released its quarterly earnings data on Tuesday, February 27th. The medical equipment provider reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.11. Masimo had a net margin of 16.49% and a return on equity of 22.91%. The business had revenue of $225.20 million during the quarter, compared to analyst estimates of $201.54 million. During the same quarter in the previous year, the business earned $0.46 EPS. Masimo’s quarterly revenue was up 22.9% compared to the same quarter last year. equities research analysts predict that Masimo Co. will post 2.81 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/masimo-co-masi-shares-sold-by-allianz-asset-management-gmbh/1906160.html.
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.